参考文献/References:
[1] Jelena I,Donna EM,Sarah R,et al.Incidence,severity and perioperative risk factors for atrial fibrillation following pulmonary resection[J].J Interact CardioVasc Thorac Surg, 2014,18(3):340-346.
[2] Andrea I,Giovanni M,Giuditta R,et al.Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study[J].Cardiothorac Surg,2012,10(7):4-12.
[3] Amar D.Postthoracotomy atrial fibrillation[J].Curr Opin Anaesthesiol,2007,20(1):43-47.
[4] Mark O,Thomas D,Yue Z,et al.Risk factors for atrial fibrillation after lung cancer surgery:Analysis of the Society of thoracic surgeons general thoracic surgery database[J].Ann Thorac Surg,2010,90(2):368-374.
[5] Takekazu I,Kaoru N,Takahiro N,et al.Risk factors predictive of atrial fibrillation after lung cancer surgery[J].Surg Today,2016,46(8):877-886.
[6] Takayoshi Y,Hidemi S,Kaoru N,et al.Is left upper lobectomy for lung cancer a risk factor for cerebral infarction?[J].Surg Today,2016,46(7):780-784.
[7] Ryu K,Toru K,Tomohiro K,et al.Outcomes of surgery for lung cancer in patients with atrial fbrillation as a preoperative comorbidity:A decade of experience at a single institution in Japan[J].Surg Today,2017,47(7):795-801.
[8] Lee SH,Ahn HJ,Yeon SM,et al.Potentially modifiable risk factors for atrial fibrillation followinglung resection surgery:A retrospective cohort study[J].Anaesthesia,2016,71(12):1424-1430.
[9] Munetaka M,Hiroyuki K,Meinoshin O,et al.Thoracic and cardiovascular surgery in Japan during 2012:Annual report by the Japanese association for thoracic surgery[J].Gen Thorac Cardiovasc Surg,2014,62(12):734-764.
[10] Wu DH,Xu MY,Mao T,et al.Risk factors for intraoperative atrial fibrillation:A retrospective analysis of 10563 lung operations in a single center[J].Ann Thorac Surg,2012,94(1):193-197.
[11] Tang J,Zhao JZ,Ren KM,et al.Risk factors of atrial fibrillation occurring after radical surgery of esophageal carcinoma[J].J Cardiothorac Surg,2019,14(1):60-67.
[12] Takuya U,Kenji S,Takeshi M,et al.Postoperative atrial fibrillation is less frequent in pulmonarysegmentectomy compared with lobectomy[J].Gen Thorac Cardiovasc Surg,2018,66(2):95-100.
[13] Stefano B,Alessandro G,Domenico V,et al.Risk factors and impact of conversion from VATS to open lobectomy:Analysis from a national database[J].Surg Endosc,2019,33(12):3953-3962.
[14] David C,Jorge A,Roopinder KS,et al. Risk of malignant cancer among women with New-Onset atrial fibrillation[J].JAMA Cardiol,2016,1(4):389-396.
[15] JCS joint working group.Guidelines for pharmacotherapy of atrial fibrillation[J].Circ J,2014,78(8):1997-2021.
[16] Gino G,Katherine N,Prashant DB,et al.Perioperative atrial fibrillation and the long-term risk of ischemic stroke[J].JAMA,2014,312(6):616-622.
[17] Takuya U,Kenji S,Takeshi M,et al.Postoperative atrial fibrillation is less frequent in pulmonary segmentectomy compared with lobectomy[J].Gen Thorac Cardiovasc Surg,2018,66(2):95-100.
[18] Ciriaco P,Mazzone P,Canneto B,et al.Supraventricular arrhythmia following lung resection for nonsmall cell lung cancer and its treatment with amiodarone[J].Eur J Cardiothorac Surg,2000,18(1):12-16.
[19] Wu CN,Ma WH,Cen QY,et al.A comparison of the incidence of supraventricular arrhythmias between thoracic paravertebral and intercostal nerve blocks in patients undergoing thoracoscopic surgery[J].Eur J Anaesthesiol,2018,35(10):792-798.
[20] Allen MS,Darling GE,Pechet TT,et al.Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer:Initial results of the randomized,prospective ACOSOG Z0030 trial[J].Ann Thorac Surg,2006,81(3):1013-1019.
[21] Iacopo F,Alessandro C,Giulia B,et al.Incidence,management,prevention and outcome of post-operative atrial fibrillation in thoracic surgical oncology[J].J Clin Med,2019,9(1):37-54.
相似文献/References:
[1]贾丽娟,杜苏丰.重组新城疫病毒疫苗rlRVG对A549荷瘤小鼠瘤体生长的抑制作用[J].陕西医学杂志,2019,(1):6.
JIA Lijuan,DU Sufeng..The tumor growth influence of recombinant NDV (rlRVG) on lung adenocarcinoma A549transfected in vivo[J].,2019,(10):6.
[2]江茂琼,贾钰铭△,叶文静,等.MDSCs对肺癌小鼠CD8+T细胞及生存期的影响研究[J].陕西医学杂志,2019,(3):293.
JIANG Maoqiong,JIA Yuming,LI Ting,et al.Effect of MDSCs on CD8 T cells and survival time of lung cancer mice[J].,2019,(10):293.
[3]李君艳,陈国荣.肺癌患者凝血指标与临床特征的关系*[J].陕西医学杂志,2019,(6):718.
LI Junyan,CHEN Guorong..The relationships between coagulation indicators and clinic characterisitics of patients with lung cancer[J].,2019,(10):718.
[4]王 玲,申 鸿.癌胚抗原、糖类抗原、CA125、血管生成素、细胞角蛋白19片段及甲胎蛋白检测在肺癌诊断中的临床研究*[J].陕西医学杂志,2019,(8):1080.
WANG Ling,SHEN Hong..The value of tumor markers CEA，CA199，CA125，Ang-2，CYFRA211 and AFP in the diagnosis of lung cancer[J].,2019,(10):1080.
[5]韩 乐,陈文娟△,雷光焰,等.microRNA21、microRNA25在肺癌组织中的表达及意义*[J].陕西医学杂志,2019,(12):1596.
HAN Le,CHEN Wenjuan,LEI Guangyan,et al.Expression and significance of microRNA21 and microRNA25 in lung cancer tissues[J].,2019,(10):1596.
[6]王 勇,张 勇,白正忠△.单操作孔完全胸腔镜与传统三孔胸腔镜治疗老年肺癌疗效对比研究*[J].陕西医学杂志,2019,(12):1670.
[7]常瑞霞,可春梅.血小板相关参数和凝血指标在肺癌治疗中的变化及意义[J].陕西医学杂志,2021,50(5):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
CHANG Ruixia,KE Chunmei.Changes and significance of platelet-related parameters and coagulation indexes in treatment of lung cancer[J].,2021,50(10):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
[8]米卫国.负压引流管在单操作孔胸腔镜下肺癌根治术中的临床应用研究[J].陕西医学杂志,2021,50(7):839.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.018]
MI Weiguo.Application effect of negative pressure drainage tube in patients undergoing radical surgery for lung cancer under single-port thoracoscopy[J].,2021,50(10):839.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.018]
[9]米 婷,王雅宁.气管镜下宏基因组学二代测序技术在肺癌鉴别诊断中的临床应用价值[J].陕西医学杂志,2022,51(4):437.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.012]
[10]张军艳,谷 俊.程序性死亡配体1在肺癌组织中的表达及其与患者病理特征和疾病预后相关性研究[J].陕西医学杂志,2022,51(7):894.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.031]
ZHANG Junyan,GU Jun.Expression of programmed death ligand 1 in lung cancer tissues and its correlation with pathological characteristics and prognosis[J].,2022,51(10):894.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.031]